Head, AI for Medicines Safety - £75,585 - £84,840 p.a. + benefits

Head, AI for Medicines Safety - £75,585 - £84,840 p.a. + benefits - Civil Service Jobs - GOV.UK You need JavaScript enabled to use this service. Cookies on Civil Service Jobs We'd like to use analytics cookies so we can understand how you use Civil Service Jobs and make improvements. We also use essential cookies to remember if you’ve accepted analytics cookies. Your cookie preferences have been set You have chosen to accept analytics cookies. You will be asked for your preferences again in 90 days. You can change your cookie settings at any time. Your cookie preferences have been set You have chosen to reject analytics cookies. You will be asked for your preferences again in 90 days. You can change your cookie settings at any time. Skip to main content GOV.UK Civil Service Jobs Beta Your feedback will help us to improve. Home Sign in to your account Cymraeg Head, AI for Medicines Safety - £75,585 - £84,840 p.a. + benefits Medicines and Healthcare Products Regulatory Agency Apply before 11:55 pm on Sunday 1st November 2026 Return to search results Details Reference number 483169 Salary £75,585 New entrants to the Civil Service will start their role on the salary band minimum of £75,585 A Civil Service Pension with an employer contribution of 28.97% GBP Job grade Grade 6 Contract type Permanent Business area MHRA - Safety and Surveillance Group - Benefit Risk Evaluation I Type of role Other Working pattern Flexible working, Full-time Number of jobs available 1 Contents Location About the job Benefits Things you need to know Apply and further information Location 10 South Colonnade, Canary Wharf London, E14 4PU. About the job Job summary We are currently looking for a Head, AI for Medicines Safety to join our Benefit Risk Evaluation I Function within the Safety & Surveillance Group. This is a full-time opportunity, on a permanent basis. The role will be based in 10 South Colonnade, Canary Wharf London, E14 4PU. Government departments and agencies are working towards implementing a minimum 60% attendance in office sites. We are currently implementing a flexible, hybrid way of working, with a minimum of 8 days per month working on site to enable the collaboration and contact with partners and stakeholders needed to deliver MHRA business. Attendance on site is driven by business needs so depending on the nature of the role, this can flex up to 12 days a month, with the remainder of time worked either remotely or in the office. Some r